Candriam Equities L Biotechnology Class C USD Cap

Registrer dig for at låse op for ratings
Fondens performance31-03-2024
Vækst af 1.000 (DKK) Avanceret graf
Candriam Equities L Biotechnology Class C USD Cap
Fond9,04,75,03,85,2
+/-Kat-9,87,717,72,51,4
+/-Indeks-16,4-2,28,0-6,4-4,8
 
Oversigt
Seneste NAV
29-04-2024
 USD 803,16
Kursændring 1 dag 0,98%
Morningstar Kategori™ Sektor - Bioteknologi, Aktier
ISIN LU0108459040
Markedsværdi i alt (mio.)
29-04-2024
 USD 1469,03
Seneste TNA(mio.)
29-04-2024
 USD 325,98
Emissionstillæg 3,50%
Løbende omkostning
01-03-2024
  1,98%
Investeringsstrategi Aktiv
Morningstar Research
Analyst Report18-03-2024
Jeffrey Schumacher, Director
Morningstar, Inc

An expanding and highly qualified team led by one of the industry’s most seasoned investors in the field, combined with a proven process give this fund an edge. The fund’s cheapest share classes receive a Morningstar Analyst Rating of Silver,...

Klik her for analytikerens rapport
Morningstar Søjler
Team24
Forening23
Proces24
Resultater
Omkostninger
Investeringsmålsætning: Candriam Equities L Biotechnology Class C USD Cap
The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies from the biotechnology sector, and to outperform the benchmark. This sub-fund may be appropriate for investors who wish to achieve this objective over a long investment holding period and who are aware of, understand and are able to bear the specific risks of the sub-fund as set out below and defined in the section entitled Risk factors in the Prospectus.
Returns
Løbende afkast29-04-2024
År til dato0,15
3-år ann.5,10
5-år ann.8,40
10-år ann.10,76
12 mdrs. udbytte i pct. 0,00
Management
Manager navn
Startdato
Rudi Van den Eynde
06-04-2000
Linden Thomson
29-02-2024
Startdato
06-04-2000
Annonce
Kategoribenchmark
Fondens indeksMorningstar indeks
NASDAQ Biotechnology TR USDMorningstar Gbl Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreIkke specifik
ComponentIkke specifik
AndetIkke specifik
Primary Objective
BevarelseNej
VækstJa
IndkomstIkke specifik
HedgingIkke specifik
AndetIkke specifik
Formuefordeling  Candriam Equities L Biotechnology Class C USD Cap29-02-2024
Morningstar stylebox®
Aktiestil
Aktivfordeling
  % Lang% Kort% Netto
Aktier95,180,0095,18
Obligationer0,000,000,00
Kontant o. lign.4,820,004,82
Andet0,000,000,00
Top 5 regioner%
USA84,28
Storbritannien5,07
Eurolande3,98
Europa - ex Euro-lande3,29
Canada1,60
Top 5 sektorer%
Healthcare100,00
Top 5 placeringerSektor%
Vertex Pharmaceuticals IncHealthcareHealthcare6,89
Regeneron Pharmaceuticals IncHealthcareHealthcare6,42
Amgen IncHealthcareHealthcare5,95
Gilead Sciences IncHealthcareHealthcare5,74
AstraZeneca PLCHealthcareHealthcare3,64
Candriam Equities L Biotechnology Class C USD Cap
For at sikre konsistens på tværs af data leveret fra forskellige kapitalforvaltere, generes de beregnede datapunkter ved hjælp af Morningstars proprietære beregningsmetode, der beskrives mere detaljeret her(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Brugervilkår        Fortrolighedspolitik        Cookie Settings        Offentliggørelser